Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer
Open Access
- 1 November 2000
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 11 (11) , 1399-1403
- https://doi.org/10.1023/a:1026595525977
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.Journal of Clinical Oncology, 1997
- Pancreatic carcinoma in perspective: A continuing challengeCancer, 1996
- A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinomaCancer, 1996
- Chemotherapy for pancreatic carcinomaCancer, 1996
- A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancerAnnals of Oncology, 1996
- Phase II study of gemcitabine in patients with advanced pancreatic cancerBritish Journal of Cancer, 1996
- Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreasInvestigational New Drugs, 1994
- Activity of cisplatin in adenocarcinoma of the pancreasEuropean Journal Of Cancer, 1993
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- A Comparison of Three Chemotherapeutic Regimens in the Treatment of Advanced Pancreatic and Gastric CarcinomaJAMA, 1985